Skip to main content

Grand Challenges

Bill & Melinda Gates Foundation

Main menu

  • About
  • Challenges
  • Awarded Grants
  • News
  • Grant Opportunities
  • Search

You are here

  1. Home
  2. Awarded Grants

Print link

Print

Highly-Parallel PCR Analysis of Latently-Infected Reservoirs

Grand Challenges ExplorationsHIV Infection30 Sep 2011

R. Paul Johnson of Emory University in the U.S. is using single-cell transcriptional profiling to identify unique biomarkers expressed in CD4+ T cells latently infected with HIV or the simian equivalent SIV. Latent infection of long-lived cells enables the viruses to survive current drug treatments, and makes the disease very difficult to cure. In Phase I, while working at Harvard Medical School in the U.S., they developed a robust high-throughput technique to identify viral genes expressed in single cells and tested it on SIV-infected macaques. In Phase II, they will use their approach to identify biomarkers on clinically relevant latently infected cell populations, which they will isolate from SIV-infected macaques treated with newly-developed antiretroviral regimens. These biomarkers could be used to design therapeutics that selectively target latently-infected cells to fully eradicate the virus.

More information about Design New Approaches to Cure HIV Infection (Round 7)

Share This Awarded Grant

  • Twitter logo Twitter
  • Facebook logo Facebook
  • LinkedIn logo LinkedIn
  • Google+ logo Google+
  • Mailto logo Mailto

Principal Investigator

R. Paul Johnson

Organization

Harvard University

Location

Cambridge, Massachusetts
United States

Contact us

Contact us

  • General Inquiries
  • Media Inquiries

Footer - Receive Updates

Receive updates

  • Sign up for email updates

Footer

  • Privacy Policy and Terms of Use
© 2003-2019. Grand Challenges. All Rights Reserved.

PLEASE REVIEW OUR UPDATED PRIVACY & COOKIES NOTICE

This site uses cookies and similar technologies to store information on your computer or device. By continuing to use this site, you agree to the placement of these cookies and similar technologies. Read our updated Privacy & Cookies Notice to learn more.